miR-494 调控成骨细胞分化及基质矿化的机制研究

doi:10.3969/j.issn.1006-6179.2024.02.014

实验动物科学 ›› 2024, Vol. 41 ›› Issue (2): 85-89.DOI: 10.3969/j.issn.1006-6179.2024.02.014

miR-494 调控成骨细胞分化及基质矿化的机制研究

(武汉市第四医院华中科技大学同济医学院附属普爱医院骨科, 武汉 430060)

收稿日期:2022-09-26 出版日期:2024-04-28 发布日期:2024-05-30
通讯作者: 程煜方( 1970—) ,男,本科,副主任医师,研究方向为西医创伤骨科,E-mail:tr349ex@ 163. com。
作者简介:程煜方( 1970—) ,男,本科,副主任医师,研究方向为西医创伤骨科,E-mail:tr349ex@ 163. com。
基金资助:
湖北省武汉市卫生健康科研基金资助( WX21Q63)

Mechanism of miR-494 Regulating Osteoblast Differentiation and Matrix Mineralization

(Department of Orthopedics,Wuhan Fourth Hospital , Puai Hospital,Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430060,China)

Received:2022-09-26 Online:2024-04-28 Published:2024-05-30

摘要/Abstract

摘要： :目的探讨 miR-494 对成骨细胞分化及基质矿化的影响及相关机制。方法选择小鼠 MC3T3-E1 成骨细胞系,随机分为对照组、miR-494 过表达组及 miR-494 抑制组。对照组不给予处理,miR-494 过表达组及 miR-494 抑制组分别加入 miR-494 mimics 转染试剂、miR-494 inhibitors 转染试剂进行细胞转染。采用碱性磷酸酶( ALP) 试剂盒检测各组细胞 ALP 活性,采用骨钙素放射免疫分析试剂盒检测各组细胞骨钙素( OC) 活性。 Vonkossa 液染色检测各组细胞钙化结节数。 qRT-PCR 检测 miR-494、磷酸酶张力蛋白同源物基因( PTEN) mRNA 表达水平,Western blot 检测细胞磷脂酰肌醇 3-激酶( PI3K) / Akt 通路蛋白表达水平,双荧光素酶报告实验验证 miR-494 与 PTEN 的靶向关系。结果双荧光素酶实验证实 PTEN 是 miR-494 的作用靶基因。 miR-494 过表达组成骨细胞 miR-494 mRNA、pAkt 蛋白明显高于对照组,PTEN mRNA、ALP 和 OC 活性、钙化结节数水平明显低于对照组;miR-494 抑制组成骨细胞 miR-494 mRNA、p-Akt 蛋白明显低于对照组、miR-494 过表达组,PTEN mRNA 水平、ALP 和 OC 活性、钙化结节数明显高于对照组、miR-494 过表达组(P<0. 05) 。结论 miR-494 可有效抑制成骨细胞分化及基质矿化过程,其机制可能与 miR-494 介导靶基因 PTEN 调控 Akt 通路有关。

关键词: miR-494, PTEN, 成骨细胞分化, 基质矿化, 机制

Abstract: Objective Effects of miR-494 on osteoblast differentiation and matrix mineralization and related mechanisms. Method mouse MC3T3-E1 osteoblasts were randomly divided into control group, miR-494 over-expression group and miR-494 inhibition group. The control group was not treated, and miR-494 over-expression group and miR-494 inhibition group were transfected with miR-494 MICs transfection reagent and miR-494 inhibitors transfection reagent respectively. ALP activity was detected by alkaline phosphatase ( ALP ) kit, and Osteocalcin ( OC ) activity was detected by osteocalcin radioimmunoassay kit. VonKossa staining was used to detect the number of calcified nodules in each group. The mRNA expression levels of miR-494 and phosphatase tensin homolog gene ( PTEN) were detected by qRT- PCR, the protein expression levels of phosphatidylinositol 3-kinase ( PI3K ) / Aktpathway were detected by Western blot, and the targeting relationship between miR-494 and PTEN was verified by double Luciferase Report experiment. Result Dual luciferase experiments confirmed that PTEN was the target gene of miR-494. miR-494 mRNA and p-Akt protein in osteoblasts with miR-494 over-expression were significantly higher than those in the control group, while PTEN mRNA, ALP and OC activity and calcified nodule number were significantly lower than those in the control group; miR-494 inhibited osteoblast miR-494 mRNA and p-Akt protein were significantly lower than those in the control group and miR-494 over-expression group, while PTEN mRNA level, ALP and OC activity and calcified nodule number were significantly higher than those in the control group and miR-494 over-expression group ( P < 0. 05 ) . Conclusion miR-494 can effectively inhibit osteoblast differentiation and matrix mineralization, and its mechanism may be related to the regulation of Akt pathway by miR-494 mediated target gene PTEN.

Key words: miR-494, PTEN;osteoblast differentiation, matrix mineralization, mechanism

中图分类号:

Q95-3

匡嘉兵郭松雷建平程煜方. miR-494 调控成骨细胞分化及基质矿化的机制研究[J]. 实验动物科学, 2024, 41(2): 85-89.

KUANG Jiabing, GUO Song, LEI Jianping, CHENG Yufang. Mechanism of miR-494 Regulating Osteoblast Differentiation and Matrix Mineralization[J]. Laboratory Animal Science, 2024, 41(2): 85-89.

0
/ / 推荐

导出引用管理器 EndNote|Ris|BibTeX

链接本文: http://www.sydwkx.com/CN/10.3969/j.issn.1006-6179.2024.02.014

http://www.sydwkx.com/CN/Y2024/V41/I2/85

http://m.chaoxing.com/mqk/read_38502727e7500f26112551c983af940dcd9ec9c0a3aff1831921b0a3ea255101fc1cf1fbb4666ae63a84a958ee7a296369390d2fe580cece3fd4edc86fb1824a8361232cc8a869e2aab163e5d6968f48?from=screen

[1]	吕淑婕, 郭雯, 方亮, 张彩云. 阿尔茨海默病发病机制及体内外模型研究进展[J]. 实验动物科学, 2024, 41(3): 79-84.
[2]	刘馨鸿, 郭超, 宋冰, 赵泓彰, 王琼, 白敏, 宋文静, 张钰, 连源, 张延英, 赵兴绪. 芍药苷抗炎作用机制研究进展[J]. 实验动物科学, 2024, 41(2): 90-95.
[3]	匡嘉兵, 郭松, 雷建平, 程煜方. miR-494 靶向 TLR-4 通路在骨质疏松发病中的作用及机制[J]. 实验动物科学, 2023, 40(6): 19-25.
[4]	赵凯悦, 刘蜜敏, 曾利, 姜海伦, 李卓荣, 徐芳, 刘睿. 基于网络药理学探讨瘤果黑种草子的抗炎机制[J]. 实验动物科学, 2022, 39(5): 7-14.
[5]	陈婷婷, 易桂生. 咳嗽变异性哮喘病理机制及造模方法的研究进展 [J]. 实验动物科学, 2021, 38(2): 74-.
[6]	高元喜, 张炜, 王玉霞, 严佳丽, 刘新宇. 南蛇藤醇介导的 PTEN 过表达增强顺铂对食管癌细胞的化学敏感性并抑制裸鼠成瘤能力[J]. 实验动物科学, 2020, 37(06): 22-.
[7]	苗茸茸，曲显俊. 抑郁症动物模型的研究进展[J]. 实验动物科学, 2019, 36(03): 80-.
[8]	胡红，李子南，郑珊，敬海明，冯颖，尤育洲，李国君，宁钧宇. 条件性基因敲除动物及其在毒理学研究领域的应用进展[J]. 实验动物科学, 2018, 35(02): 79-.
[9]	陈臻毅, 徐强, 梁自豪, 饶军华. 动脉粥样硬化发病机制及其动物模型研究进展[J]. 实验动物科学, 2015, 32(04): 54-58.
[10]	翟新验,王小珂. 人畜共患病耐药机制[J]. 实验动物科学, 2005, 22(03): 37-40.
[11]	刘金明,林矫矫,傅志强,李浩,魏梅雄,孙军,张亮,何艳燕,蒋守富,刘瑞三. 东方田鼠抗日本血吸虫病机制研究[J]. 实验动物科学, 2003, 20(S1): 141-142.
[12]	尹海林. 加强项目管理,建立动物实验的伦理学评价机制[J]. 实验动物科学, 2003, 20(S1): 104-106.
[13]	宋淑霞,王秀芳,侯洁,吕占军. 痢疾志贺氏菌(Sh.dysenteriae)对荷瘤小鼠免疫保护及作用机制初报[J]. 实验动物科学, 1998, 15(02): 0-0.

miR-494 调控成骨细胞分化及基质矿化的机制研究

Mechanism of miR-494 Regulating Osteoblast Differentiation and Matrix Mineralization

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 13

编辑推荐

Metrics